Literature DB >> 9848440

Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin.

M F Palepou1, A P Johnson, B D Cookson, H Beattie, A Charlett, N Woodford.   

Abstract

The susceptibilities to mupirocin of 102 selected clinical isolates of Staphylococcus aureus and of control strain S. aureus NCTC 6571 were determined by disc diffusion (using discs containing 5, 15, 25, 30, 50 and 200 microg of mupirocin) and Etest and the results were compared with MICs determined using an agar incorporation method. On the basis of agar incorporation MICs, 42 isolates were sensitive to mupirocin (MIC < or = 4 mg/L), 39 showed low-level resistance (MICs = 8-128 mg/L) and 22 were highly resistant (MICs > or = 256 mg/L) and contained the mupA resistance gene. Using Stokes' criteria, none of the discs used gave major errors (sensitive isolates classified as highly resistant) or very major errors (highly resistant isolates classified as sensitive) in assigning a category of susceptibility, but minor errors (a difference of one category) were noted with all strengths. The best correlation with agar incorporation MIC was obtained with 25 microg mupirocin discs, which classified correctly 98 (95%) isolates, while worse correlations were noted with 5 microg and 200 microg discs which are the only types currently available commercially, for which there were 47 and 30 minor errors, respectively. The MICs found by Etest were the same as, or lower than, those determined by agar incorporation. Etests classified correctly all 42 mupirocin-sensitive isolates, 19 (49%) low-level resistant isolates and 16 (73%) highly resistant isolates. Two isolates that contained the mupA gene and showed agar incorporation MICs of 256 mg/L and 512 mg/L were not classified as highly resistant by any of the diffusion methods used. Agar incorporation MIC determination, possibly supported by detection of the mupA gene, offers the most effective means of identifying high-level mupirocin resistance in S. aureus, although the Etest also proved to be reproducible. However, we conclude that 25 microg discs warrant further evaluation for possible use in clinical laboratories, as they appear to be more reliable than the discs currently available.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9848440     DOI: 10.1093/jac/42.5.577

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  Detection of methicillin and mupirocin resistance in Staphylococcus aureus isolates using conventional and molecular methods: a descriptive study from a burns unit with high prevalence of MRSA.

Authors:  P U Krishnan; K Miles; N Shetty
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

2.  High-level mupirocin resistance within methicillin-resistant Staphylococcus aureus pandemic lineages.

Authors:  Eduardo Pérez-Roth; Celeste López-Aguilar; Julia Alcoba-Florez; Sebastián Méndez-Alvarez
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 3.  Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.

Authors:  Deborah A Williamson; Glen P Carter; Benjamin P Howden
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

4.  Multicenter study to determine disk diffusion and broth microdilution criteria for prediction of high- and low-level mupirocin resistance in Staphylococcus aureus.

Authors:  Jana M Swenson; Betty Wong; Andrew E Simor; Richard B Thomson; Mary Jane Ferraro; Dwight J Hardy; Janet Hindler; James Jorgensen; L Barth Reller; Maria Traczewski; Linda K McDougal; Jean B Patel
Journal:  J Clin Microbiol       Date:  2010-05-05       Impact factor: 5.948

5.  Evaluation of mupA EVIGENE assay for determination of high-level mupirocin resistance in Staphylococcus aureus.

Authors:  Anne K I Rasmussen; Robert L Skov; Richard A Venezia; Jennifer K Johnson; Henrik Stender
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

6.  Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use.

Authors:  Erik Bathoorn; David J Hetem; Jeriela Alphenaar; Johannes G Kusters; Marc J M Bonten
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

7.  A double-blind, randomized, controlled trial of topical polysporin triple compound versus topical mupirocin for the eradication of colonization with methicillin-resistant Staphylococcus aureus in a complex continuing care population.

Authors:  S O'Grady; Z Hirji; B Pejcic-Karapetrovic; S Fung; H Dedier; J Takata-Shewchuk; K Zhang; J Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

8.  Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection.

Authors:  Susan S Huang; Daniel J Diekema; David K Warren; Gianna Zuccotti; Patricia L Winokur; Shailesh Tendolkar; Linda Boyken; Rupak Datta; Rebecca M Jones; Melissa A Ward; Tanya Aubrey; Andrew B Onderdonk; Christian Garcia; Richard Platt
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

9.  Mupirocin resistance in nasal carriage of Staphylococcus aureus among healthcare workers of a tertiary care rural hospital.

Authors:  Dardi Charan Kaur; Pandey Aastha Narayan
Journal:  Indian J Crit Care Med       Date:  2014-11

10.  Resistance pattern of mupirocin in methicillin-resistant Staphylococcus aureus in trauma patients and comparison between disc diffusion and E-test for better detection of resistance in low resource countries.

Authors:  Nonika Rajkumari; Purva Mathur; Nidhi Bhardwaj; Gunjan Gupta; Rajrani Dahiya; Bijayini Behera; Mahesh Chandra Misra
Journal:  J Lab Physicians       Date:  2014-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.